Importance of hyperhomocysteinemia as a risk factor for venous thromboembolism in a Taiwanese population. A case-control study

Thrombosis Research

Volumn 102, Issue 5, 2001, Pages 387-395

  Hsu, Tsu Shiu ^a,b   Hsu, Lung An ^a   Chang, Chi Jen ^a   Sun, Chien Feng ^a   Ko, Yu Lin ^a   Kuo, Chi Tai ^a   Chiang, Cheng Wen ^a   Lee, Ying Shiung ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b NONE   (Taiwan)

Author keywords

Hyperhomocysteinemia; Venous thromboembolism

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5 LEIDEN; CARDIOLIPIN ANTIBODY; HOMOCYSTEINE; LUPUS ANTICOAGULANT; PROTEIN C; PROTEIN S;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; GENE MUTATION; HUMAN; HYPERHOMOCYSTEINEMIA; LEG THROMBOSIS; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN DEFICIENCY; RISK FACTOR; TAIWAN; THROMBOEMBOLISM;

ADULT; AGED; CASE-CONTROL STUDIES; FACTOR V; FEMALE; GENOTYPE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MUTATION; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; PREVALENCE; RISK FACTORS; TAIWAN; THROMBOEMBOLISM; THROMBOPHILIA; VENOUS THROMBOSIS;

EID: 0035370630     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(01)00262-6     Document Type: Article

References (42)

1. Thrombophilia as a multigenic disease
2. Thrombophilia: Disorders predisposing to venous thromboembolism
3. Epidemiology of factor V Leiden: Clinical implications
4. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease, probable benefits of increasing folic acid intakes
5. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis
6. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase
7. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke and venous thrombosis in apparently healthy men
8. Vascular pathology of homocysteinemia: Implications for the pathogenesis of arteriosclerosis
9. The pathogenesis of coronary artery disease. A possible role for methionine metabolism
10. B vitamins and risk of coronary atherosclerosis
11. The association of elevated plasma homocyst(e)ine with progression of symptomatic peripheral arterial disease
12. High prevalence of moderate hyperhomocyst(e)inemia in patients with juvenile venous thrombosis
13. Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis?
14. Plasma homocysteine levels in patients with deep venous thrombosis
15. Hyperhomocyst(e)inemia and the increased risk of venous thromboembolism: More evidence from a case-control study
16. Plasma homocysteine levels in patients with deep venous thrombosis
17. Common C677T polymorphism in the methylenetetrahydrofolate reductase gene increases the risk for deep vein thrombosis in patients with predisposition of thrombophilia
18. Hyperhomocysteinemia and venous thrombosis: A meta-analysis
19. Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematous
20. Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism
21. Fasting plasma homocysteine levels do not predict the occurrence of deep-vein thrombosis after elective hip replacement surgery
22. Hyperhomocysteinemia is a risk factor of recurrent venous thromboembolism
23. The mutation Ala677→Val in the methylenetetrahydrofolate reductase gene: A risk factor for arterial disease and venous thrombosis
24. The methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of the FV Leiden and the prothrombin A20210 mutation
25. Thermolabile methylenetetrahydrofolate reductase and factor V Leiden in the risk of deep-vein thrombosis
26. A common mutation in the methylenetetrahydrofolate reductase gene (C677T) increases the risk for deep-vein thrombosis in patients with mutant factor V (factor V:Q506)
27. Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: Prevalence and risk assessment
28. No evidence for an increased risk of venous thrombosis in patients with factor V Leiden by the homozygous 677 C to T mutation in the methylenetetrahydrofolate-reductase gene
29. Thrombophilic predisposition in stroke and venous thromboembolism in Danish patients
30. Prevalence of mild hyperhomocysteinaemia and association with thrombophilic genotypes (factor V Leiden and prothrombin G20210A) in Italian patients with venous thromboembolic disease
31. The prevalence of C677T mutation in the methylenetetrahydrofolate reductase gene and its association with venous thrombophilia in Taiwanese Chinese
32. Homocysteine and vascular disease
33. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population
34. Intermediate homocysteinemia: A thermolabile variant of methylenetetrahydrofolate reductase
35. The G1691A mutation of the coagulation factor V gene (factor V Leiden) is rare in Chinese: An analysis of 618 individuals
36. High prevalence of antithrombin III, protein C and protein S deficiency, but no factor V Leiden mutation in venous thrombophilic Chinese patients in Taiwan
37. Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis
38. Protein C deficiency in a controlled series of unselected outpatients: An infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study)
39. Causes of venous thrombosis in fifty Chinese patients
40. Pathogenetic factors underlying juvenile deep vein thrombosis (DVT) in Indians
41. Anticardiolipin antibodies in patients with venous thrombosis
42. Spanish Multicentric Study on Thrombophilia (EMET), Barcelona, Spain. Laboratory evaluation and clinical characteristics of 2,132 consecutive unselected patients with venous thromboembolism - Results of the Spanish Multicentric Study on Thrombophilia (EMET-Study)